The firm says the shares have been down recently on competitive concerns from NewAmsterdam’s (NAMS) CETP inhibitor, obicetrapib, which recently had positive Phase 3 data. However, investors are ...

NewAms­ter­dam Phar­ma’s car­dio drug suc­ceed­ed in a third read­out this year, show­ing that obice­trapib could low­er a type of lipopro­tein that car­ries cho­les­terol in the … ...

may reflect nuggets of cardiovascular outcomes results that NewAmsterdam included in its readout on the CETP inhibitor. After one year, the biotech saw a 21% drop in major adverse cardiovascular ...

Obicetrapib’s safety profile, including its potential impact on blood pressure — a concern for drugs of its kind, known as CETP inhibitors — were also comparable to a placebo. A higher percentage of ...

MANILA, Philippines — Due to an alleged conflict of interest, a group of seafarers has asked Department of Migrant Workers (DMW) Assistant Secretary Jerome Pampolina to inhibit from drafting the ...

A SEAFARER'S group urged on Saturday an official of the Department of Migrant Workers (DMW) to inhibit himself from drafting the implementing rules and regulations (IRR) of the Magna Carta of Filipino ...

Based on this, industrialists have been given time to produce similar orders from the NGT for the 15 MLD CETP. Kale Pani Da Morcha member Jaskirat Singh accused the government of delaying tactics ...

Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, P. R. China School of Traditional Chinese ...

Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy ...

Obicetrapib is a selective inhibitor of cholesteryl ester transfer protein (CETP). By blocking CETP, these inhibitors work to increase high-density lipoprotein (HDL) cholesterol and lower ...